South Korea · Delayed Price · Currency is KRW AprilBio Statistics
Total Valuation
AprilBio has a market cap or net worth of KRW 1.51 trillion. The enterprise value is 1.41 trillion.
| Market Cap | 1.51T |
| Enterprise Value | 1.41T |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
AprilBio has 23.34 million shares outstanding. The number of shares has increased by 3.94% in one year.
| Current Share Class | 23.34M |
| Shares Outstanding | 23.34M |
| Shares Change (YoY) | +3.94% |
| Shares Change (QoQ) | -1.65% |
| Owned by Insiders (%) | 29.91% |
| Owned by Institutions (%) | 17.36% |
| Float | 16.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 693.19 |
| PB Ratio | 15.63 |
| P/TBV Ratio | 15.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -145.28 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -389.32 |
Financial Position
The company has a current ratio of 174.90, with a Debt / Equity ratio of 0.01.
| Current Ratio | 174.90 |
| Quick Ratio | 173.83 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -11.74 |
Financial Efficiency
Return on equity (ROE) is -10.39% and return on invested capital (ROIC) is -4.76%.
| Return on Equity (ROE) | -10.39% |
| Return on Assets (ROA) | -4.62% |
| Return on Invested Capital (ROIC) | -4.76% |
| Return on Capital Employed (ROCE) | -7.52% |
| Weighted Average Cost of Capital (WACC) | 13.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +275.60% in the last 52 weeks. The beta is 1.62, so AprilBio's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +275.60% |
| 50-Day Moving Average | 60,307.00 |
| 200-Day Moving Average | 36,298.80 |
| Relative Strength Index (RSI) | 51.14 |
| Average Volume (20 Days) | 389,627 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AprilBio had revenue of KRW 2.17 billion and -9.73 billion in losses. Loss per share was -429.00.
| Revenue | 2.17B |
| Gross Profit | 2.15B |
| Operating Income | -7.26B |
| Pretax Income | -9.73B |
| Net Income | -9.73B |
| EBITDA | -6.57B |
| EBIT | -7.26B |
| Loss Per Share | -429.00 |
Balance Sheet
The company has 92.77 billion in cash and 497.99 million in debt, with a net cash position of 92.27 billion or 3,953.00 per share.
| Cash & Cash Equivalents | 92.77B |
| Total Debt | 497.99M |
| Net Cash | 92.27B |
| Net Cash Per Share | 3,953.00 |
| Equity (Book Value) | 96.32B |
| Book Value Per Share | 4,160.86 |
| Working Capital | 94.17B |
Cash Flow
In the last 12 months, operating cash flow was -3.34 billion and capital expenditures -287.84 million, giving a free cash flow of -3.63 billion.
| Operating Cash Flow | -3.34B |
| Capital Expenditures | -287.84M |
| Depreciation & Amortization | 691.58M |
| Net Borrowing | -360.97M |
| Free Cash Flow | -3.63B |
| FCF Per Share | -155.52 |
Margins
| Gross Margin | 98.94% |
| Operating Margin | -334.44% |
| Pretax Margin | -447.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AprilBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.94% |
| Shareholder Yield | -3.94% |
| Earnings Yield | -0.65% |
| FCF Yield | -0.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 31, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Oct 31, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |